Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10356329
United States Court of Appeals for the Fourth Circuit
Real Time Medical Systems, Inc. v. PointClickCare Technologies, Inc.
No. 10356329 · Decided March 12, 2025
No. 10356329·Fourth Circuit · 2025·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Fourth Circuit
Decided
March 12, 2025
Citation
No. 10356329
Disposition
See opinion text.
Full Opinion
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 1 of 58
PUBLISHED
UNITED STATES COURT OF APPEALS
FOR THE FOURTH CIRCUIT
No. 24-1773
REAL TIME MEDICAL SYSTEMS, INC.,
Plaintiff - Appellee,
v.
POINTCLICKCARE TECHNOLOGIES, INC., d/b/a PointClickCare,
Defendant - Appellant.
-----------------------------------------------
AMERICAN HOSPITAL ASSOCIATION; ELECTRONIC HEALTH RECORD
ASSOCIATION,
Amici Supporting Appellant.
Appeal from the United States District Court for the District of Maryland, at Greenbelt.
Paula Xinis, District Judge. (8:24-cv-00313-PX)
Argued: January 28, 2025 Decided: March 12, 2025
Before GREGORY, WYNN, and HEYTENS, Circuit Judges.
Affirmed by published opinion. Judge Wynn wrote the opinion, in which Judge Gregory
and Judge Heytens joined.
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 2 of 58
ARGUED: Jeremy Michael Bylund, KING & SPALDING LLP, Washington, D.C., for
Appellant. Marie Celeste Bruce, RIFKIN WEINER LIVINGSTON, LLC, Bethesda,
Maryland, for Appellee. ON BRIEF: William C. Jackson, GOODWIN PROCTER LLP,
Washington, D.C.; Nicole Bronnimann, Houston, Texas, Rod J. Rosenstein, Amy R.
Upshaw, Joshua N. Mitchell, KING & SPALDING LLP, Washington, D.C., for Appellant.
Michael T. Marr, Madelaine Kramer Katz, RIFKIN WEINER LIVINGSTON, LLC,
Bethesda, Maryland, for Appellee. James E. Tysse, Kelly M. Cleary, Margaret O. Rusconi,
Emily I. Gerry, Stephanie Ondroff, AKIN GUMP STRAUSS HAUER & FELD LLP,
Washington, D.C., for Amici Curiae.
2
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 3 of 58
WYNN, Circuit Judge:
Plaintiff Real Time Medical Systems, LLC 1 provides analytics services to skilled
nursing facilities by accessing health records from Defendant PointClickCare
Technologies, Inc., which operates a system that hosts patients’ electronic health records.
Real Time frequently accesses the health records in question using “bots,” or automated
users. PointClickCare claims that Real Time’s use of bots raises security and system-
performance concerns and has blocked the profiles of users whom it suspects have accessed
its system using bots.
This appeal arose when Real Time sued to stop PointClickCare from restricting its
access to PointClickCare’s systems, and the district court granted Real Time a preliminary
injunction. For the reasons that follow, we affirm.
I.
The following facts are based on the record as it comes to us on this preliminary,
interlocutory appeal.
A.
Real Time is a Maryland health-analytics company that services skilled nursing
facilities and other providers. Dr. Scott Rifkin founded the company more than a decade
ago because, in his view, while nursing-home staff know how to look for and treat the
“fires” (such as vomiting and chest pain), they are not as aware of the little signs (such as
1
While our case caption labels Real Time as a corporation—in line with the caption
in the complaint and the caption used below—Real Time’s counsel clarified at oral
argument that Real Time is an LLC.
3
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 4 of 58
fluctuations in weight or bowel movements) that could signal an impending crisis like
sepsis. J.A. 392. 2 Nor do nursing homes have the staff to perform that kind of detailed
monitoring.
So, Real Time aims to evaluate patients’ medical records—as close to real time as
possible—to look for what Dr. Rifkin calls “interventional moments.” J.A. 393. When such
an interventional moment arises, Real Time alerts medical staff and provides a treatment
protocol. The goal is to catch a problem early, while it is easily treatable, to avoid a hospital
admission and heightened risk of death.
While it is not the only company providing this service, Real Time has been
particularly successful in performing this work. E.g., J.A. 175–86 (affidavits and
declarations from medical providers and others involved in running nursing facilities
attesting to Real Time’s benefits and averring that without these services their “facilities
are likely, over any substantial amount of time, to see an increase in resident
hospitalizations and/or deaths”). This type of analytics is a game-changer because “up until
not too long ago, the data that was used to make decisions about . . . patient care in nursing
homes[] was” often “30, 60, 90 days[] old”—which is helpful for making long-term,
prospective decisions, but irrelevant for a patient on the verge of crisis today. J.A. 569.
A recent academic study showed that hospital readmissions significantly decreased
where Real Time’s program was implemented. The researchers noted that, if all skilled
nursing facilities could reduce their readmissions to the rate shown for the Real Time-
2
Citations to the “J.A.” refer to the Joint Appendix filed by the parties in this appeal.
4
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 5 of 58
associated facilities in their study, the Centers for Medicare & Medicaid Services would
save around $2.8 billion annually. Today, Real Time’s customers include around 1,700
skilled nursing facilities as well as health insurers, CVS Health Corporation, and the state
of Maryland.
To conduct its work, Real Time needs access to the patient’s medical chart. But
gone are the days of “the old paper charts that [a doctor] used to walk up and open.” J.A.
417. Nowadays, charts are stored in Electronic Health Records (“EHR”) systems. While
there are multiple EHR companies, PointClickCare provides EHR support to more than
half of nursing homes in the United States, serves 1.6 million patients at around 27,000
facilities, and hosts about 6 million users on its platform. The vast majority of Real Time’s
skilled-nursing-facility customers—roughly 1,400 of its 1,700 facilities, covering roughly
140,000 patients—use PointClickCare’s system to host their medical records.
PointClickCare also offers medical providers various support products, such as for
invoicing, and uses an automated process to push out 1.2 million medication
administrations per day. And as discussed further below, for the last few years
PointClickCare has been trying to enter the analytics space as another competitor to Real
Time.
Medical records remain the property of the patient, even when stored on an EHR
system. So, for Real Time to access the medical records necessary to conduct its analytics,
it enters agreements with its customer facilities under which the patient (via the customer
facility) provides Real Time with permissions and login information. PointClickCare also
enters agreements with its customer facilities. Its standard agreement permits customers to
5
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 6 of 58
assign users (such as Real Time) to access the database. Thus, Real Time and
PointClickCare have mutual customers but do not contract with each other.
Once Real Time receives login information from its customer, it regularly
downloads information from PointClickCare’s system to perform its analytics. Because of
the amount of data needed, it uses bots to perform this task. Using humans instead would
require 450 people working around the clock seven days a week just to pull the data from
PointClickCare’s system. Real Time Med. Sys., Inc. v. PointClickCare Techs., Inc., No.
8:24-cv-00313-PX, 2024 WL 3569493, at *2 (D. Md. July 29, 2024) (citing J.A. 509–10).
PointClickCare introduced testimony that it would prefer hundreds of human users to a bot
because the humans would take longer to perform the task, thus spreading out the strain on
the system. But Real Time’s Chief Technology Officer, Christopher Miller, testified that
such a setup would not be financially feasible because the cost of the staffing would exceed
the fees Real Time charges its customers.
Real Time’s bots download basic, standardized data, as well as a bespoke “Follow
Up Questions” Report, which includes point-of-care data and is customizable by the
customer. Point-of-care data is data that is “recorded generally at bedside,” J.A. 453, such
as “a patient’s use of feeding tubes or number of bowel movements,” J.A. 17. By volume,
roughly 70 to 75% of the data Real Time uses for its analysis comes from the Follow Up
Questions Reports.
After importing the data into its system, Real Time standardizes it, then analyzes it
to look for interventional moments and pushes out alerts to providers as needed. This
process is “fully automated,” although humans perform routine quality-assurance
6
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 7 of 58
evaluations. J.A. 458.
Real Time has been using bots to pull data from PointClickCare’s EHR since March
2014. Real Time has never experienced a security breach, has never been told by a
governmental client that its security systems are ineffective, and has the highest security
certification offered in the health-data space. It uses the same automated process with other
EHR providers without issue. And PointClickCare’s Senior Vice President of Software-as-
a-Service Operations, Bachar Fourati, and Chief Product Officer, Robert Boyle, each
conceded they were not aware of any security breach resulting from “anything Real Time
has done in [PointClickCare’s] system.” J.A. 656; accord J.A. 781–82, 794.
Indeed, for roughly eight years, Real Time accessed PointClickCare’s systems using
bots without PointClickCare raising any concerns about the practice. True, the standard
agreement that PointClickCare has used with its customers for at least five years instructed
that—subject to the 21st Century Cures Act and its regulations, which are central to this
case and discussed further below—“[c]ustomer[s] shall not, and shall ensure Users [like
Real Time] do not,” use bots to extract data or access services in a way that adversely
impacts performance. J.A. 1074. But, for all those years, PointClickCare never complained
to Real Time about its bot usage. None of the other EHR companies with which Real Time
works have complained or suggested that Real Time’s actions cause performance issues in
their systems, either. Nor is there any indication PointClickCare ever sued a customer for
breach of the agreement “related to usage of automated users.” J.A. 653.
B.
PointClickCare began to consider competing with Real Time in the health-analytics
7
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 8 of 58
arena around 2020 or 2021. Shortly thereafter, it started to acquire Real Time’s competitors
to support this endeavor. PointClickCare’s competitive product must rely on the same
records Real Time accesses—and it does not restrict its own automated access to that
data—although PointClickCare’s counsel argued below that its own automated access does
not pose security or performance concerns because the systems are integrated.
In 2022, the state of Maryland’s health information exchange, Chesapeake Regional
Information System for Our Patients (“CRISP”), put out a request for proposals. Reacting
to perceived failures during the COVID pandemic, Maryland sought to “use technology to
mitigate having full-blown communicable disease outbreaks in congregate care settings,
specifically in nursing homes.” J.A. 562. At least three companies bid on the project,
including Real Time and PointClickCare. Real Time ultimately won the contract, and the
program is ongoing today.
In the spring of 2022, Real Time reached out to PointClickCare, seeking to access
some of PointClickCare’s data directly (without the need to download) through direct
integration between Real Time and PointClickCare’s Marketplace Application
Programming Interface (“Marketplace API”). “Within about a week,” PointClickCare
informed Real Time “that there wasn’t a category within the marketplace that fit” or that
Real Time “qualified for,” but that Real Time could instead pursue direct integration
through PointClickCare’s “United States Core Data for Interoperability” (“USCDI”)
connector program. J.A. 499, 1307. Those talks ultimately fizzled out, and Real Time
continued to access PointClickCare’s system using bots, without complaint from
PointClickCare.
8
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 9 of 58
Then in November 2022, without warning, PointClickCare introduced into its
system a CAPTCHA wall. CAPTCHA stands for “Completely Automated Public Turing
Test to Tell Computers and Humans Apart.” Real Time, 2024 WL 3569493, at *1. “A
CAPTCHA is a well-known internet security device designed to ensure that humans, not
automated software or ‘bots,’ are attempting to gain access to the online platform.” Id. at
*2. The CAPTCHAs that PointClickCare introduced in November 2022 were the type that
is often presented on today’s websites, such as:
J.A. 1109; see J.A. 716. The text or other puzzle is meant to be decipherable by a human
but difficult or impossible for a bot to solve.
PointClickCare claims it introduced the CAPTCHA wall after “numerous incidents
and issues” had impacted performance and because it was “concerned about security,”
though it has not pointed to any specific incidents or reasons for concern preceding the
introduction of the CAPTCHAs. J.A. 703. Nevertheless, after encountering the
CAPTCHAs—and after hearing from a customer that PointClickCare had told the customer
that Real Time was slowing down its systems—Real Time discussed the issue with
9
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 10 of 58
PointClickCare and reduced its data pulls from four to two times a day. PointClickCare
again did not tell Real Time that it could not use bots or that bots posed a security risk.
With no indication from PointClickCare that it was concerned about blocking access from
all bots, including those controlled by a well-known entity like Real Time, Real Time
“created a team tasked with manually deciphering [the] CAPTCHA images,” after which
its bots could perform their function. J.A. 130.
Also in November 2022, PointClickCare started an internal “watch list” of users it
thought were bots based on historical usage of the system and resource consumption. J.A.
723. According to PointClickCare, users who are not on the watch list are never presented
with CAPTCHAs, but once a user is placed on the watch list, that user will have to solve a
CAPTCHA when it logs in and also when it accesses certain pages. Once a user ID is
placed on the watch list, it is never taken off, and so even if a human logs in using that
account, they will be faced with CAPTCHAs.
PointClickCare’s witness, Fourati, waffled on what level of usage led a user to be
placed on the watch list, ultimately asserting that it would be “a minimum of ten times the
[usage of a] normal user,” where a “normal user” makes around “500 to 1,000 requests per
day.” J.A. 771–72. That would mean that a user making roughly 5,000 to 10,000 requests
per day should be watch-listed. However, the district court cast doubt on Fourati’s
testimony, noting that one of PointClickCare’s few exhibits demonstrating bot activity
showed a user making well over 5,000 requests per day for more than six months straight
in 2023 and 2024—and at or above 10,000 requests a day for the last two and a half
months—before it was apparently watch-listed.
10
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 11 of 58
Fourati also testified that, sometime early in 2023, PointClickCare received a
customer complaint related to its system’s performance. After investigating,
PointClickCare discovered that, around April 5 and 6, 2023, usage from user IDs that the
customer said belonged to Real Time was exceedingly high. PointClickCare introduced
two graphs from those dates purporting to show this usage. Those two graphs from April
2023 are the only concrete data PointClickCare provided regarding Real Time’s bots’
effect on its systems, 3 see Real Time, 2024 WL 3569493, at *5–6, *8, even though Fourati
testified that PointClickCare documents “every time there’s an outage” and “track[s] all
those incidents,” J.A. 691.
On April 14, 2023, PointClickCare adopted an internal bot-prevention policy.
However, the policy was updated twice in September 2023, and it is not clear that the most
up-to-date version is available in the record. Real Time, 2024 WL 3569493, at *5. While
the policy states that PointClickCare will send a series of warnings to customers related to
3
In his declaration, Fourati also cited an “incident [which] involved [Real Time’s]
bot user submitting an extreme number of reports, making excessive database queries that
caused database collapse, impacting 10,000 patients; 1,450 of which were Maryland-based
patients. In that particular circumstance, it took about an hour to bring the server and
database back online for PointClickCare’s customers.” J.A. 243. PointClickCare cites this
assertion in its brief and claims that it is supported by “documentation.” Opening Br. at 26;
see id. at 18–19. In fact, PointClickCare did not introduce any documentary evidence for
this alleged incident. Fourati’s declaration did not even provide a date. Nor did he explain
how he knew the user in question was associated with Real Time. Moreover, he did not
mention this incident at all in his testimony at the hearing, despite spending significant time
discussing alleged bot-related performance issues. Rather, when asked whether the two
graphs from April 2023 were “all that[ was] in [his] affidavit [sic] as far as Real Time,”
Fourati responded, “Yeah, that’s fair.” J.A. 803. Finally, counsel also did not point to this
alleged incident during the motion argument below. We thus follow the district court’s lead
and do not consider this unsupported allegation.
11
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 12 of 58
bot usage, there is no evidence it ever did so. Nor does the policy include any objective
criteria related to what level of usage triggers a user’s placement on the watch list.
Around May 2023, Real Time and PointClickCare entered potential merger and
acquisition talks and, on May 31, executed a non-disclosure agreement (“NDA”). In mid-
June, pursuant to the NDA, Real Time began executing a premerger information exchange,
under which it “pretty much shared everything with [PointClickCare]” related to its data-
analytics methodology, customers, and finances. J.A. 408. Real Time also gave
PointClickCare a demonstration of its product. Although it was clear during these
discussions that Real Time’s business model was built around bots, PointClickCare yet
again did not raise concerns about security during these talks. Real Time’s Chief Strategy
and Development Officer, Timothy Buono, testified that after the parties discussed Real
Time’s security certification, “that was the end of the discussion at least related to
security,” as far as he could recall. J.A. 589.
In early October 2023, however—again without warning—PointClickCare
escalated its CAPTCHA process by introducing indecipherable CAPTCHA images, such
as:
J.A. 130. “Real Time’s [human] operators were largely unsuccessful at deciphering these
new CAPTCHA images[.]” J.A. 131. By definition, CAPTCHAs are meant to be solvable
12
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 13 of 58
by humans, so an indecipherable image is technically no longer a “CAPTCHA.” For ease
of reference, however, and consistent with the practice of the parties and the district court,
we will refer to these images as “indecipherable” or “unsolvable” CAPTCHAs.
At the same time, PointClickCare began blocking users if (or rather, when) they
could not solve its unsolvable CAPTCHAs. Once one of its users was blocked, Real Time
had to ask its customer to reset the account—only to be faced with CAPTCHAs again and,
after again failing, end up being re-blocked. This wasted the time of both Real Time and
its customers. Moreover, “the introduction of [the] new images resulted in Real Time being
unable to retrieve [Follow Up Questions] Reports for dozens of Nursing Facilities,” with
Real Time’s access to data for at least seventy-five nursing facilities being “adversely
impacted,” including its access for twenty-one Maryland nursing facilities being “entirely
severed.” J.A. 131.
It was only at this point that Real Time learned PointClickCare was not interested
in pursuing acquisition. See Real Time, 2024 WL 3569493, at *3 (“Acquisition talks appear
to have continued long enough for [PointClickCare] to learn of Real Time’s business
details without sharing any of its own.”). PointClickCare never provided Real Time a
reason for cutting off the acquisition talks.
The indecipherable CAPTCHAs were “turned off” for a few days in late October
2023. Id. at *4 (citing J.A. 134). But by early November, they were back, and Real Time’s
users at “over 700 of [its] 1400 facilities that utilized PointClickCare[’s system] were fully
locked out.” J.A. 474.
13
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 14 of 58
C.
Faced with this pressing issue, Real Time sought a solution with PointClickCare. It
reduced the volume of its data pulls by half yet again, cutting them to “just once a day” and
running them overnight, both to get as complete a picture of the day as possible and “as a
gesture of good will, to try to just be in the system when fewer users are.” J.A. 451–52.
The parties discussed whether Real Time could join PointClickCare’s Marketplace
API. But there were two issues with this approach: first, the Marketplace would include
only about 30% of the data Real Time needed; and second, PointClickCare wanted Real
Time to sign its standard marketplace agreement in order to join the Marketplace API, but
the agreement included numerous terms Real Time found objectionable, including a
requirement that it not develop or commercialize products that PointClickCare deemed, in
its “sole discretion,” to be “directly competitive” to its own products. J.A. 133. Given that
PointClickCare was by now a competitor to Real Time’s health-analytics product, Real
Time believed it would have been “immediately” in breach of any such agreement. J.A.
593.
The parties also again discussed USCDI connector access, but, like the Marketplace
API, the USCDI would provide less than 30% of the needed data, which “would be
insufficient to produce or provide value.” J.A. 455; see J.A. 509. Another possible avenue
for obtaining data, called a “data relay,” would provide a data export to the customer
nursing facility, which Real Time could then obtain from the customer. J.A. 515. However,
it, too, “would [provide] under 30 percent of the data . . . volume that [Real Time] work[s]
with” because it would lack point-of-care data unless the parties negotiated to include it.
14
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 15 of 58
J.A. 516. Even then, however, it would pose an issue because the data would be provided
directly to the nursing facilities, most of which do not have the technical capability to
provide it to Real Time in a usable format.
Faced with these hurdles, technical employees within both companies began an
initially productive dialogue regarding an alternative solution: Real Time would join the
Marketplace API, and PointClickCare would export the data not available via the
Marketplace API, either sending it to Real Time through a secure method or “stor[ing] [it]
for [Real Time] to securely retrieve.” J.A. 473.
Chief Technology Officer Miller testified that Real Time would prefer to get its data
in this way, which would allow it to receive the data “in one big . . . bunch” rather than
having to run bots to download the needed data. J.A. 512. Real Time’s Chief Information
Security Officer, Andrew Lister, explained that it has such an arrangement with another
company with which it works for four of its nursing-facility customers. He testified that
this arrangement “tells [Real Time] that it’s feasible to do and not that difficult to do, and
it doesn’t take that long . . . to even set it up or even run it,” based on his conversations
with that other company. J.A. 535. Further, this solution would resolve PointClickCare’s
cited security and system-degradation concerns related to Real Time’s bot usage by
eliminating the need for bots.
The parties’ technical employees began developing the “connector to the API,” and
got about a third of the way through that process. J.A. 468. Meanwhile, Chief Strategy and
Development Officer Buono suggested to PointClickCare that the parties “draft an
agreement from scratch,” but PointClickCare “insisted that [Real Time] mark up
15
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 16 of 58
[PointClickCare’s standard marketplace] agreement.” J.A. 591. So, on November 29, Real
Time sent redlines to the Marketplace API agreement that it indicated would resolve its
concerns with the contract. 4 Real Time also proposed a fee structure for the combined
Marketplace and data-export solution. 5
But then PointClickCare suddenly ceased communicating about this possible
solution. Miller testified that PointClickCare’s communications “just stopped. . . . I would
occasionally ask a question, they were quick to respond, spin up a phone call. But I became
aware that there was a breakdown. We were told we weren’t going to get what we had been
discussing, and so it just simply stopped.” J.A. 474. PointClickCare never indicated to Real
Time that there were any technical barriers to the proposed data export or Marketplace API
connection. Nor did it respond to Real Time’s proposed redlines to the Marketplace API
agreement or to its fee proposal.
Instead, on December 14, 2023, PointClickCare simply informed Real Time that it
did not intend to pursue the agreement: it “would not entertain any changes to the
marketplace agreement”; the data “extracts would not be made available”; and “[t]he use
4
One of the redlines Real Time made to the agreement was to strike the prohibitions
on Real Time’s use of bots. However, Buono testified that if Real Time could get the
needed information through a combination of the Marketplace API and data extracts, he
“would imagine” the prohibition on bots “would be a non-issue.” J.A. 610.
5
The precise fee proposal is not clear from the record. The parties agree that
PointClickCare requests $65 per facility per month for regular access to the Marketplace
API, or $125 per facility per month for premium access, which appears to include at least
some items not relevant here. Buono testified that Real Time’s initial counteroffer was $30
and $60, respectively. Later, however, he testified that Real Time had countered with an
offer of $70 to cover the information it was requesting. Thus, when PointClickCare’s
lawyer asked whether $65 was unreasonable, he said that it was not, as Real Time had
“countered with $70.” J.A. 607.
16
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 17 of 58
of data relay would not be made available . . . as a potential solution,” nor would
PointClickCare “agree to any changes” to the data-relay output. J.A. 594. PointClickCare
also notified Real Time that it did not intend to give Real Time a demonstration of its
product pursuant to the NDA.
Two of Real Time’s witnesses testified that PointClickCare executives told them
that PointClickCare was not interested in collaboration because it felt it could outcompete
Real Time. See J.A. 409–10 (Dr. Rifkin testifying that PointClickCare’s senior vice
president, Travis Palmquist, told him this); J.A. 594–95 (Buono testifying that
PointClickCare’s vice president of partnerships and strategic alliances, Marino Cherubin,
told him this); see also J.A. 162 (Buono’s affidavit). PointClickCare denies that its
executives made such statements—and notes that it works with other competitors—but has
not provided any explanation for why it ceased talks.
For example, while Buono testified that Cherubin told him that PointClickCare
“would not entertain any changes to the [M]arketplace [API] agreement,” J.A. 594,
Cherubin conceded that the agreement was normally “subject to modification through
negotiation,” J.A. 858–59, and that when PointClickCare entered into data-exchange
agreements with other companies—including three he identified as competitors—“there
were modifications to the agreement,” J.A. 852. Yet, Cherubin admitted, PointClickCare
simply “did not respond” to Real Time’s redline of the agreement. J.A. 859.
Having failed to reach a business resolution, Real Time sued PointClickCare in
Maryland state court on January 9, 2024. It asserted seven claims, of which two are relevant
on appeal: unfair competition (Count II) and tortious interference with Real Time’s
17
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 18 of 58
contracts with the skilled nursing facilities (Count IV). Among other relief, it sought an
injunction to stop PointClickCare from using the indecipherable CAPTCHA images and
deactivating Real Time’s accounts. PointClickCare quickly removed the case to federal
court 6 and then moved to dismiss for failure to state a claim.
6
In its notice of removal, PointClickCare invoked both federal question jurisdiction
and diversity jurisdiction. Notice of Removal at 1, Real Time, No. 8:24-cv-00313-PX (D.
Md. Jan. 31, 2024), ECF No. 1. Whether this case implicates a federal question is a
complicated question. See Republican Nat’l Comm. v. N.C. State Bd. of Elections, 120
F.4th 390, 400 (4th Cir. 2024) (describing the applicable four-part test); Burrell v. Bayer
Corp., 918 F.3d 372, 376 (4th Cir. 2019) (noting that “federal jurisdiction over state-law
causes of action” lies “only in a special and small class of cases” (internal quotation marks
omitted)). We need not resolve that issue because we conclude that the federal courts
possess diversity jurisdiction over this matter. See 28 U.S.C. § 1332(a)(2).
PointClickCare asserted in its notice of removal that it “is incorporated in Ontario,
Canada and maintains its principal place of business in Ontario, Canada.” Notice of
Removal at 5; accord J.A. 12 (complaint alleging that PointClickCare “a foreign
corporation, with its principal place of business” in Ontario, Canada, and “is registered to
do business in Minnesota”). The notice of removal also correctly identified Real Time as
an LLC. “For purposes of diversity jurisdiction, the citizenship of a limited liability
company . . . is determined by the citizenship of all of its members[.]” Cent. W. Va. Energy
Co. v. Mountain State Carbon, LLC, 636 F.3d 101, 103 (4th Cir. 2011). But the notice of
removal indicated that PointClickCare was “unaware of the identities of [Real Time’s]
member(s) and therefore their place(s) of citizenship.” Notice of Removal at 5. That is
insufficient. See Moses Enters., LLC v. Lexington Ins. Co., 66 F.4th 523, 526 n.1 (4th Cir.
2023) (noting a defect where “the complaint contains no mention of [an LLC’s] members’
citizenships”); Ellenburg v. Spartan Motors Chassis, Inc., 519 F.3d 192, 200 (4th Cir.
2008) (stating that the removing party is held to same pleading standard as plaintiff filing
initial complaint); accord Stewart v. Gruber, No. 23-30129, 2023 WL 8643633, at *2 (5th
Cir. Dec. 14, 2023) (per curiam) (faulting removing defendants for not identifying
citizenship of plaintiff LLC’s members); Roberts v. Nix, No. 1:22-cv-00235, 2022 WL
4372086, at *4 (S.D. W. Va. Sept. 21, 2022) (same).
However, “28 U.S.C. § 1653 allows ‘[d]efective allegations of jurisdiction’ to ‘be
amended’ on appeal.” Moses Enters., 66 F.4th at 526 n.1. And “[a]t oral argument, [counsel
for Real Time] asserted, without contradiction”—and in consultation with her client—that
none of Real Time’s members are residents of Canada. Thompson v. Ciox Health, LLC, 52
F.4th 171, 173 n.1 (4th Cir. 2022); see Oral Arg. at 15:50–16:22,
https://www.ca4.uscourts.gov/OAarchive/mp3/24-1773-20250128.mp3. “Treating that
18
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 19 of 58
Soon after Real Time filed suit, sometime in February 2024, PointClickCare’s usage
of indecipherable CAPTCHA images and blocking of Real Time’s accounts slowed to a
trickle for several months. Then, in mid-May 2024, Real Time saw the “return of some of
the indecipherable CAPTCHAs” in larger numbers, J.A. 477, and even more
indecipherable images appeared, such as this one:
J.A. 1108. PointClickCare introduced testimony that it had implemented a system whereby
watch-listed users would face an initial, regular, solvable CAPTCHA; if the user could not
solve that CAPTCHA, they would be faced with increasingly difficult CAPTCHAs until
they reached an unsolvable one, and eventually were locked out. (Real Time put forward
testimony contending that it was sometimes locked out even if it did happen to solve one
of the more challenging CAPTCHAs.) PointClickCare explained that, at that point, even if
the user reset their account and tried to log in with a human user, they would always be
uncontested allegation as a constructive amendment of the complaint under 28 U.S.C.
§ 1653, we are satisfied the district court had jurisdiction to consider” the preliminary-
injunction proceedings. Thompson, 52 F.4th at 173 n.1.
19
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 20 of 58
brought straight to the unsolvable CAPTCHA. This new process caused Real Time to
rapidly lose access to its accounts for more than 600 of its skilled-nursing-facility
customers.
So, on May 30, 2024, Real Time filed the motion for a preliminary injunction at
issue in this appeal. It indicated that it had no problem with decipherable CAPTCHAs, but
that PointClickCare’s use of indecipherable CAPTCHAs and practice of locking out
accounts posed a significant threat to Real Time’s ability to provide its services. In
response, PointClickCare paused the indecipherable CAPTCHAs for Real Time’s users,
instead presenting them only with the first-level, normal CAPTCHAs. 7 But PointClickCare
informed the district court that, if the preliminary injunction was denied, it would continue
to use indecipherable CAPTCHAs and lock out suspected bot users.
To facilitate PointClickCare pausing the use of indecipherable CAPTCHAs for Real
Time’s users, Real Time sent PointClickCare a list of 572 of its users, and PointClickCare
determined that 119 of those users were on the watch list (out of 570 total users on the
watch list). Real Time’s counsel represented, however, that the list of 572 Real Time user
IDs it sent did not include “ones that were [already] locked out.” J.A. 714. Our own review
of the lists supports this assertion and suggests that at least 131 users on the watch list,
7
To be sure, Real Time introduced two videos from early June in which humans
sought to log in with watch-listed usernames, were faced with indecipherable CAPTCHAs,
and were ultimately locked out. However, we are not aware of evidence that Real Time has
had any issues logging in since the district court granted the preliminary injunction.
20
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 21 of 58
rather than 119, belong to Real Time. 8 It is therefore unclear from the present record what
percentage of the watch list is made up of Real Time users, but it appears to be nearly a
quarter at minimum.
After receiving numerous exhibits and holding a motion hearing across two full
days, the district court granted the preliminary injunction on July 29. Real Time, 2024 WL
3569493, at *1. PointClickCare timely appealed and successfully moved this Court to
accelerate the briefing schedule. Two organizations, the Electronic Health Record
Association and the American Hospital Association, filed a joint Amicus Brief in support
of PointClickCare’s appeal. We have jurisdiction over this interlocutory appeal pursuant
to 28 U.S.C. § 1292(a)(1).
II.
To begin, the district court did not determine whether Real Time sought, through an
injunction, to preserve or alter the status quo. Real Time, 2024 WL 3569493, at *6.
Preliminary injunctions that alter the status quo are known as “mandatory preliminary
injunctions” and are highly disfavored. Pierce v. N.C. State Bd. of Elections, 97 F.4th 194,
8
Reviewing the full watch list and identifying those usernames that directly
referenced Real Time (by including something like “realtime” or “rtime”) or used an
individual’s name included in user IDs on Real Time’s list (such as D. Lister or P. Charles),
we identified 128 suspected Real Time users on the full watch list. Of those 128 users that
appear to belong to Real Time and are on the full watch list, only 116 were on the list of
non-locked-out users that Real Time sent to PointClickCare. In other words, there appear
to be at least 12 additional users associated with Real Time that were watch-listed beyond
the 119 on Real Time’s list. There may well be more, as we could only search the full
watch list for those names clearly associated with Real Time.
21
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 22 of 58
209 (4th Cir. 2024). The district court concluded it did not need to resolve the issue because
it would reach the same result either way. Real Time, 2024 WL 3569493, at *6.
Whatever the merits of that determination, we are convinced this case involves a
normal, status-quo-maintaining preliminary injunction, not a mandatory one. “We have
defined the status quo for this purpose to be ‘the last uncontested status between the parties
which preceded the controversy.’” League of Women Voters of N.C. v. North Carolina, 769
F.3d 224, 236 (4th Cir. 2014) (quoting Pashby v. Delia, 709 F.3d 307, 320 (4th Cir. 2013)).
Here, the “last uncontested status” existed before PointClickCare’s October 2023
introduction of indecipherable CAPTCHAs and blocking users that failed them.
Immediately after that shift in PointClickCare’s practices, Real Time sought to resolve the
issue directly with PointClickCare; when that failed, it sued. Shortly thereafter, the
indecipherable CAPTCHAs slowed to a trickle for several months. Once they reemerged
in May, Real Time rapidly moved for a preliminary injunction. Real Time thus consistently
challenged the use of the indecipherable CAPTCHAs and the blocking policy, and
requested the court’s intervention as soon as it became clear that PointClickCare intended
the policy to stay.
“To win . . . a preliminary injunction, [p]laintiffs must demonstrate that (1) they are
likely to succeed on the merits; (2) they will likely suffer irreparable harm absent an
injunction; (3) the balance of hardships weighs in their favor; and (4) the injunction is in
the public interest.” League of Women Voters, 769 F.3d at 236 (citing Winter v. Nat. Res.
Def. Council, Inc., 555 U.S. 7, 20 (2008)). “Although [p]laintiffs need not establish a
22
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 23 of 58
certainty of success, they must make a clear showing that they are likely to succeed at trial.”
Roe v. Dep’t of Def., 947 F.3d 207, 219 (4th Cir. 2020) (cleaned up).
The standard for a plaintiff to receive a preliminary injunction—even one merely
seeking to preserve the status quo—is thus steep. But that does not mean the defendant has
no role to play. While plaintiffs bear the burden of demonstrating each of the four
preliminary-injunction elements, “the burdens at the preliminary injunction stage track the
burdens at trial”—meaning, for example, defendants must shoulder the burden of proving
an affirmative defense, even at the preliminary-injunction stage. Gonzales v. O Centro
Espirita Beneficente Uniao do Vegetal, 546 U.S. 418, 429 (2006); accord Ramirez v.
Collier, 595 U.S. 411, 425 (2022) (describing burden-shifting analysis under the Religious
Land Use and Institutionalized Persons Act and noting that “[t]his allocation of respective
burdens applies in the preliminary injunction context”).
Further, arguments that a defendant might make on appeal from an order granting a
preliminary injunction are subject to the same rules as with any appellant: we may deem
an argument not properly before us if the defendant fails to sufficiently raise it before the
district court or in its opening brief. E.g., Miranda v. Garland, 34 F.4th 338, 350 (4th Cir.
2022) (defendant appealing grant of preliminary injunction failed to preserve argument by
making only “cursory,” footnoted reference to it); Metro. Reg’l Info. Sys., Inc. v. Am. Home
Realty Network, Inc., 722 F.3d 591, 602 n.13 (4th Cir. 2013) (defendant appealing grant of
preliminary injunction failed to preserve argument by raising it for the first time in its reply
brief); U.S. Dep’t of Lab. v. Wolf Run Mining Co., 452 F.3d 275, 283 (4th Cir. 2006)
23
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 24 of 58
(defendant appealing grant of preliminary injunction failed to preserve argument by failing
to raise it before district court). 9
“We review the decision to grant or deny a preliminary injunction for an abuse of
discretion. Abuse of discretion is a deferential standard, and we may not reverse so long as
the district court’s account of the evidence is plausible in light of the record viewed in its
entirety. A clear error in factual findings or a mistake of law is grounds for reversal.” Roe,
947 F.3d at 219 (cleaned up).
III.
With these standards in mind, we turn to an analysis of the preliminary injunction
in this case. We begin with the question of whether Real Time has demonstrated a sufficient
likelihood of success on the merits. We agree with the district court that it has.
“Although the Complaint alleges six causes of action, Real Time presse[d] only
three claims for purposes of injunctive relief: tortious interference with business relations,
unfair competition, and breach of contract as a third-party beneficiary.” Real Time, 2024
9
Some of our prior cases, including those cited here, “use ‘waiver’ and ‘forfeiture’
interchangeably, but the terms technically have different meanings. ‘Forfeiture’ refers to a
party’s inadvertent failure to raise an argument; a court has discretion to reach a forfeited
issue. By contrast, ‘waiver’ refers to a knowing, and intelligent decision to abandon an
issue. Unlike a forfeited issue, a court does not have discretion to reach an issue that a party
has waived.” Stokes v. Stirling, 64 F.4th 131, 136 n.3 (4th Cir.) (citations omitted), cert.
denied, 144 S. Ct. 377 (2023).
24
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 25 of 58
WL 3569493, at *7. The district court only addressed the first two claims and concluded
that Real Time was likely to succeed on both. Id.
We agree as to the unfair-competition claim, so we need not analyze the tortious-
interference claim. E.g., Roe, 947 F.3d at 219 (affirming order granting preliminary
injunction where “[t]he district court did not err in concluding that [the p]laintiffs are likely
to succeed on the merits of at least one claim”).
A.
When faced with a question of state law, we must look to decisions of the state’s
highest court and, if those decisions do not resolve the matter, “‘predict’ how [that] court
would rule on the state law issue in question.” Koppers Performance Chems., Inc. v.
Argonaut-Midwest Ins. Co., 105 F.4th 635, 640 (4th Cir.) (quoting Knibbs v. Momphard,
30 F.4th 200, 213 (4th Cir. 2022)), cert. denied, 145 S. Ct. 570 (2024). “In doing so, the
decisions of [state] intermediate appellate courts ‘constitute the next best indicia of what
state law is,’” although those “decisions are never binding and ‘may be disregarded if the
federal court is convinced by other persuasive data that the highest court of the state would
decide otherwise.’” Colo. Bankers Life Ins. Co. v. Acad. Fin. Assets, LLC, 60 F.4th 148,
154 (4th Cir. 2023) (quoting Priv. Mortg. Inv. Servs., Inc. v. Hotel & Club Assocs., Inc.,
296 F.3d 308, 312 (4th Cir. 2002)). Other forms of data to consider include “the canons of
construction, restatements of the law, treatises, recent pronouncements of general rules or
25
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 26 of 58
policies by the state’s highest court, well considered dicta, and the state’s trial court
decisions.” Moore v. Equitrans, L.P., 27 F.4th 211, 220 (4th Cir. 2022) (cleaned up).
There is no specific test for a claim of unfair competition under Maryland common
law. ClearOne Advantage, LLC v. Kersen, --- F. Supp. 3d ---, No. 23-cv-03446-JKB, 2024
WL 4754051, at *6 (D. Md. Nov. 12, 2024); accord Command Tech., Inc. v. Lockheed
Martin Corp., No. 0469 Sept. Term 2014, 2015 WL 6470277, at *8 (Md. Ct. Spec. App.
Oct. 27, 2015) (referring to the tort’s “amorphous contours”). Rather, the Supreme Court
of Maryland “has preserved a high degree of flexibility in the law of unfair competition.”
Delmarva Sash & Door Co. of Md. v. Andersen Windows, Inc., 218 F. Supp. 2d 729, 733
(D. Md. 2002). It is defined, generally, as “damaging or jeopardizing another’s business by
fraud, deceit, trickery or unfair methods of any sort,” and must be evaluated case-by-case.
Balt. Bedding Corp. v. Moses, 34 A.2d 338, 342 (Md. 1943).
The prototypical unfair-competition case involves alleged violation of a business’s
trademark. E.g., Scotch Whisky Ass’n v. Majestic Distilling Co., 958 F.2d 594, 597 (4th
Cir. 1992). However, the Supreme Court of Maryland 10 has long made clear the tort
extends beyond that context.
For example, in 1943, it explained that, “[e]xpressed in simple words, [the purpose
of the doctrine of unfair competition] was to prevent dealings based on deceit and
dishonesty, and was, at first,—approximately a hundred years ago,—applied only to what
10
“In 2022, . . . Maryland changed the name of its highest court from the Court of
Appeals of Maryland to the Supreme Court of Maryland. We use the current name.” Kim
v. Bd. of Educ. of Howard Cnty., 93 F.4th 733, 739–40 n.6 (4th Cir. 2024).
26
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 27 of 58
were then termed ‘trade mark cases.’ Since that time the gradual tendency of the Courts
has been to extend the scope of the law to all cases of unfair competition in the field of
business.” Balt. Bedding Corp., 34 A.2d at 342. So, for example, this Court has previously
upheld a jury verdict finding Maryland unfair competition based on interference in product-
distribution contracts. Trimed, Inc. v. Sherwood Med. Co., 977 F.2d 885, 890–91 (4th Cir.
1992); cf. Paccar Inc. v. Elliot Wilson Capitol Trucks LLC, 905 F. Supp. 2d 675, 691–92
(D. Md. 2012) (noting that Trimed “strongly suggests that a finding of unfair competition
can be based on an array of actions that interfere with vital aspects of business, such as
customer relations, product shipments, or pricing”).
“In making a case-specific determination as to whether conduct constitutes unfair
competition, courts must be careful to protect legitimate competition among business
rivals. . . . Business torts do not exist to allow courts to retroactively pick winners and
losers in the marketplace but to enforce only minimum standards of conduct.” Command
Tech., 2015 WL 6470277, at *8–9 (citing Edmondson Vill. Theatre v. Einbinder, 116 A.2d
377, 382 (Md. 1955)). “[T]he courts are solicitous to prevent unfair competition in
business, and to protect against unfair practices those persons who have established and
developed a business or product stamped in the public mind with the impress of the
builder’s skill or reputation; but the courts are equally solicitous to encourage fair
competition and thereby protect the public against the evils of monopolies.” Edmondson
Vill. Theatre, 116 A.2d at 382. For this reason, Maryland’s highest court has noted, “[t]he
courts must be careful to guard against extending the meaning of ‘unfair competition’ to
cover acts which may be unethical yet not illegal.” Id.
27
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 28 of 58
However, as this Court has previously explained in reviewing this case law,
Maryland “has never required an unlawful act as an essential element of an unfair
competition claim.” Trimed, 977 F.2d at 891 (emphasis added) (first citing Balt. Bedding
Corp., 34 A.2d at 342; then citing Edmondson Vill. Theatre, 116 A.2d at 382; and then
citing Cavalier Mobile Homes, Inc. v. Liberty Homes, Inc., 454 A.2d 367, 374 (Md. Ct.
Spec. App. 1983)) (rejecting defendant’s argument “that the [jury] instructions were
contrary to Maryland law because, essentially, they permitted the jury to find unfair
competition from lawful, competitive conduct”). Instead, we apparently understood the
Maryland courts’ reference to an “illegal” act to mean merely that the action must meet a
certain threshold to qualify as tortious unfair competition—not that the action must be
illegal under another source of law. Cf. Command Tech., 2015 WL 6470277, at *8 (finding
no unfair competition where the defendant “never had a legal obligation to any party” to
take the sought-after action “and, thus, did not unfairly take advantage of any party’s
reasonable expectations”).
In any event, in this case, Real Time does argue that PointClickCare’s use of
indecipherable CAPTCHAs and choice to block certain users is illegal under another
source of law: 11 the information-blocking provision of the federal 21st Century Cures Act
11
It seems the question could just as easily be framed as Real Time pointing to a
tortiously unfair act, and PointClickCare raising compliance with the Cures Act as a
defense to show that its behavior is by definition not unfair. Cf. Amicus Br. at 29
(conceding that “the conduct underlying an information blocking violation can be used to
prove the elements of a Maryland common law claim, including an unfair competition . . .
claim, in an appropriate circumstance”). Nevertheless, we follow the parties’ framing of
the issue.
28
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 29 of 58
of 2016 (“Cures Act”). See 21st Century Cures Act, Pub. L. No. 114-255, § 4004, 130 Stat.
1033, 1176–80 (2016) (codified as amended at 42 U.S.C. § 300jj-52). “Thus, says Real
Time, [PointClickCare] has competed unfairly by severing Real Time’s ability to provide
analytics for no legitimate purpose other than to gain an economic advantage in Real
Time’s market.” Real Time, 2024 WL 3569493, at *7.
PointClickCare responds that Real Time cannot rely on a violation of the Cures Act
to support a claim of unfair competition under Maryland law; that even if it can,
PointClickCare did not violate the Cures Act; and that even if it did, Real Time’s claims
fail for other reasons. We disagree on each point, which we consider in turn.
B.
PointClickCare first contends that Real Time cannot rely on a Cures Act violation
to support a Maryland unfair-competition claim. This argument has two subparts:
PointClickCare argues that (1) a federal statute lacking a private right of action cannot
support a Maryland unfair-competition claim; and (2) the Cures Act preempts any state-
law claim.
PointClickCare has failed to preserve both arguments. It failed to preserve the first
by failing to present it below. See Wolf Run Mining Co., 452 F.3d at 283. And it failed to
preserve the second by taking only a “passing shot” at the issue in its opening brief. Mod.
Perfection, LLC v. Bank of Am., N.A., 126 F.4th 235, 240 n.1 (4th Cir. 2025); see Miranda,
34 F.4th at 350–51; Opening Br. at 61 (devoting a two-sentence paragraph to the matter).
Nevertheless, because Real Time does not invoke forfeiture or waiver, both arguments
have been addressed in the briefs on appeal (including briefing from Amici), and this
29
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 30 of 58
appeal’s preliminary posture means that these matters are likely to be brought to the district
court on remand, we exercise our discretion to review the arguments. Stokes v. Stirling, 64
F.4th 131, 136 n.3 (4th Cir.) (“[A] court has discretion to reach a forfeited issue.”), cert.
denied, 144 S. Ct. 377 (2023); see also Jordan v. Large, 27 F.4th 308, 312 n.4 (4th Cir.
2022) (this Court “can look” at waived arguments when “the waiver itself has been
waived”); United States v. Newby, 91 F.4th 196, 200 n.* (4th Cir. 2024) (an appellee that
fails to assert forfeiture in its brief “has forfeited any such forfeiture argument” in turn).
1.
The first question is whether a Maryland claim for unfair competition can be
premised in part on a federal statute that both parties agree lacks a private right of action.
We conclude it can.
In our 2005 decision in College Loan Corp. v. SLM Corp., we held that “the lack of
a [federal] statutory private right of action does not, in and of itself, bar a plaintiff from
relying on violations of that statute as evidence supporting a state law claim.” Coll. Loan
Corp. v. SLM Corp., 396 F.3d 588, 599 n.9 (4th Cir. 2005) (citing Medtronic, Inc. v. Lohr,
518 U.S. 470, 487 (1996) (opinion of Stevens, J.) (violation of federal statute without “an
implied private right of action” could support a state common-law cause of action)). We
therefore rejected the notion that a plaintiff “was not entitled to utilize evidence that [a
defendant] had violated [a federal statute lacking a private right of action] and its
regulations to satisfy elements of its state law claims.” Id. at 597. “To the contrary,” we
elaborated, “the Supreme Court (and this Court as well) has recognized that the availability
of a state law claim is even more important in an area where no federal private right of
30
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 31 of 58
action exists.” Id. at 598 (first citing Worm v. Am. Cyanamid Co., 970 F.2d 1301, 1308 (4th
Cir. 1992); and then citing Silkwood v. Kerr-McGee Corp., 464 U.S. 238, 251 (1984)); see
also Burrell v. Bayer Corp., 918 F.3d 372, 377 (4th Cir. 2019) (noting state law could
provide remedies despite lack of federal private right of action).
To be sure, more recently, we have explored the limits of this principle. In Bauer v.
Elrich, we concluded that the plaintiffs could not “circumvent[]” the lack of a private right
of action in a federal statute “by invocation of a state’s law of taxpayer standing.” Bauer v.
Elrich, 8 F.4th 291, 295 (4th Cir. 2021). But in that case, the claim “at its core” sought to
“enforce a federal statute”; the plaintiffs “d[id] not seek to advance any state law right or
enforce any duty established under state law.” Id. at 297. We concluded that the state
“taxpayer standing doctrine does not grant any substantive rights to . . . taxpayers, but
merely confers standing in state court for taxpayers to enforce a right or obligation imposed
by some other provision of law.” Id. at 298 (emphasis added). Thus, we rejected the
plaintiffs’ contention that the alleged “violation of federal law merely [was] an element of
their cause of action authorized under [state] law.” Id. Rather, “[b]ecause federal law
create[d] the substantive requirement that the plaintiffs [sought] to enforce, we look[ed] to
federal law to determine whether a private remedy [was] authorized” (which it was not).
Id. at 299.
In so ruling, we relied on a Supreme Court decision establishing that plaintiffs
cannot avoid the absence of a private right of action in a federal statute merely by seeking
to enforce compliance with that statute as a provision of a contract to which the plaintiff
claimed to be a third-party beneficiary. Id. at 299–300 (citing Astra USA, Inc. v. Santa
31
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 32 of 58
Clara County, 563 U.S. 110, 113–14, 116–18, 119 n.4 (2011)). We noted that “[t]he
Supreme Court declined the plaintiff’s attempt to bring a breach of contract claim that was
‘in substance one and the same’ as a suit to enforce the governing statute directly.” Id. at
300 (emphasis added) (quoting Astra USA, 563 U.S. at 114). Nevertheless, we did not
purport to overrule College Loan Corp.; to the contrary, we recognized that some of our
prior cases had allowed “federal standards merely [to] serve[] as evidence that the state law
duty had been violated.” Id. at 301. And we have continued to rely on the relevant portion
of College Loan Corp. after Bauer. E.g., Guthrie v. PHH Mortg. Corp., 79 F.4th 328, 340
(4th Cir. 2023) (citing College Loan Corp., 396 F.3d at 597–99), cert. denied, 144 S. Ct.
1458 (2024).
In sum, our case law establishes that it is acceptable to use a violation of a federal
statute as evidence supporting a state law claim—but not to advance a state claim that is
merely a shell for an otherwise-unavailable federal claim.
The claim Real Time advances falls squarely in the “acceptable” camp. Real Time
does not seek merely to enforce the Cures Act on its own terms, using state law to evade
the lack of a private right of action under federal law. Rather, it seeks to use a violation of
the Cures Act as evidence to support an element of a larger state-law claim for unfair
competition—that is, to show that certain actions taken by its competitor are unfair and
wrongful. That is permissible under our precedent.
It also appears to us that the Supreme Court of Maryland would permit such a claim
to proceed. Again, Maryland unfair competition is a highly “flexib[le]” tort, Delmarva Sash
& Door Co., 218 F. Supp. 2d at 733, which is to be evaluated case-by-case, and which
32
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 33 of 58
seeks to prevent competitors from using “fraud, deceit, trickery or unfair methods of any
sort” to “damag[e] or jeopardiz[e] another’s business,” Balt. Bedding Corp., 34 A.2d at
342 (emphasis added). And Maryland’s intermediate appellate court has allowed a plaintiff
pursuing a different state tort to point to a federal law lacking a private right of action. See
Magee v. DanSources Tech. Servs., Inc., 769 A.2d 231, 257 (Md. Ct. Spec. App. 2001)
(“[The plaintiff]’s evidence of [federal] health care benefit fraud satisfied the second
‘unvindicated public policy mandate’ element of a[ state] abusive discharge cause of
action.”).
Moreover, whether a party “had a legal obligation” to take (or not take) a certain
action can inform the unfair-competition analysis under Maryland law. Command Tech.,
2015 WL 6470277, at *8; cf. Goldman v. Harford Rd. Bldg. Ass’n, 133 A. 843, 846 (Md.
1926) (“Competition is the state in which men live and is not a tort, unless the nature of
the method employed is not justified by public policy, and so supplies the condition to
constitute a legal wrong.”). Maryland case law makes clear that this legal obligation can
arise from federal law. E.g., Barnett v. Md. State Bd. of Dental Exam’rs, 444 A.2d 1013,
1022 (Md. 1982) (relying on the federal Lanham Act). And the fact that the Cures Act does
not include a private right of action does not mean that its information-blocking provision
does not impose a “legal obligation” on PointClickCare; it undisputedly does. Cf. Intus
Care, Inc. v. RTZ Assocs., Inc., No. 24-cv-01132-JST, 2024 WL 2868519, at *2 (N.D. Cal.
June 5, 2024) (concluding that a Cures Act violation would constitute an “independently
wrongful” act sufficient to support a claim for intentional interference with prospective
economic advantage under California law, even though the Cures Act lacks a private right
33
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 34 of 58
of action).
PointClickCare’s only contrary citation is to a single District of Maryland case. See
Opening Br. at 59 (citing Waypoint Mgmt. Consulting, LLC v. Krone, No. 19-cv-2988-
ELH, 2022 WL 2528465, at *61 (D. Md. July 6, 2022)). Aside from being a federal district
court case—not a Maryland state case—PointClickCare quotes the case out of context. All
the court in that case stated was: “I am unaware of any case law that suggests that [the
plaintiff] may predicate a State law claim for unfair competition on a purported violation
of [a certain regulation].” Waypoint Mgmt. Consulting, 2022 WL 2528465, at *61. While
the court did note that the regulation in question lacked a private right of action, it also
noted that the duties imposed by the regulation did not fall on the defendant. Id.
We do not find that highly fact-specific, federal case particularly helpful in
predicting how the Supreme Court of Maryland would decide this matter. Instead, for the
reasons discussed, we think the Supreme Court of Maryland would permit a plaintiff to
rely on an information-blocking violation of the Cures Act to support a claim of unfair
competition.
2.
That leaves the matter of preemption. PointClickCare halfheartedly argues that Real
Time’s unfair-competition claim is preempted by federal law because the claim would
“interfere with” federal law. Opening Br. at 61. Amici flesh out this argument, contending
that in this highly regulated space, actors need a “standardized and common understanding
of what conduct” violates the Cures Act—which they argue is best achieved by exclusive
federal enforcement. Amicus Br. at 18.
34
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 35 of 58
Amici raise genuine concerns about the predictability of the law for regulated
entities. But because “states are separate sovereigns,” “we apply the Supremacy Clause
with the basic assumption that Congress did not intend to displace state law.” N. Va. Hemp
& Agric., LLC v. Virginia, 125 F.4th 472, 492 (4th Cir. 2025) (cleaned up). This
presumption “is even stronger against preemption of state remedies, like tort recoveries,
when no federal remedy exists.” Coll. Loan Corp., 396 F.3d at 597 (quoting Abbot ex rel.
Abbot v. Am. Cyanamid Co., 844 F.2d 1108, 1112 (4th Cir. 1988)); see Silkwood, 464 U.S.
at 251 (“It is difficult to believe that Congress would, without comment, remove all means
of judicial recourse for those injured by illegal conduct.”).
Preemption can take three basic forms: express preemption, where “Congress
clearly expresses an intention for a federal law to preempt state law”; field preemption,
where “Congress expresses an intent to preempt state regulation in a certain area by
comprehensively regulating that area,” “reflect[ing] an intent to displace state law
altogether”; and conflict preemption, which occurs where either “compliance with both
federal and state regulations is impossible” (direct conflict preemption) or “a state law
stands as an obstacle to the accomplishment and execution of the full purposes of the
federal law” (obstacle preemption). N. Va. Hemp & Agric., 125 F.4th at 492–93. “A state
law may pose an obstacle to federal purposes by interfering with the accomplishment of
Congress’s actual objectives, or by interfering with the methods that Congress selected for
meeting those legislative goals.” Coll. Loan Corp., 396 F.3d at 596.
PointClickCare and Amici rely only on the second type of conflict preemption:
obstacle preemption. See Opening Br. at 61 (arguing that allowing Real Time’s unfair-
35
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 36 of 58
competition claim to proceed would “interfere with Congress’s . . . scheme”); Amicus Br.
at 15 (“[A]llowing such claims would frustrate the federal enforcement scheme Congress
did provide.”). “But a court should not find conflict preemption unless preemption was ‘the
clear and manifest purpose of Congress.’” N. Va. Hemp & Agric., 125 F.4th at 493 (quoting
Arizona v. United States, 567 U.S. 387, 400 (2012)). We see no such indication here. To
the contrary, the Cures Act plainly contemplates that the states will regulate in this area, as
it notes that information blocking can include “practices that restrict authorized access,
exchange, or use under applicable State or Federal law.” 42 U.S.C. § 300jj-52(a)(2)(A)
(emphasis added).
Certainly, Congress provided a federal mechanism for resolving Cures Act
violations: “[t]he inspector general of the Department of Health and Human Services . . .
may investigate any claim that” an entity engaged in information blocking, and where the
inspector general finds such information blocking has occurred, the Secretary of Health
and Human Services must order a civil monetary penalty of up to $1,000,000 per violation.
Id. § 300jj-52(b).
But the mere fact that Congress provided a federal executive avenue for resolving
instances of information blocking is insufficient to conclusively show that Congress
intended to preempt any state-law judicial cause of action based on behavior that would
qualify as information blocking under the Cures Act. As we have previously held, “the fact
that only the Secretary is authorized to enforce” a federal statute does not “compel the
conclusion that [a plaintiff]’s pursuit of its state law claims, relying in part on violations of
the [statute] or its regulations, will obstruct the federal scheme.” Coll. Loan Corp., 396
36
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 37 of 58
F.3d at 598; see also Guthrie, 79 F.4th at 341 (“[W]e see no reason why the mere fact that
state law claims provide broader remedies than federal law means the state claims are
preempted.”).
And here, such an interpretation would mean that Congress recognized that states
might define information blocking—“practices that restrict authorized access, exchange,
or use under applicable State . . . law”—but, in the same breath (yet without actually
explicitly saying so), forbid states from acting on instances of information blocking. 42
U.S.C. § 300jj-52(a)(2)(A). Neither PointClickCare nor Amici provide any explanation for
how we could reach such a counterintuitive result.
We therefore conclude that Real Time may rest a Maryland unfair-competition
claim in part on a violation of the Cures Act’s prohibition on information blocking. So we
turn to whether Real Time is likely to succeed on the merits of its assertion that there is
such a violation here.
C.
The Cures Act describes itself as “An Act [t]o accelerate the discovery,
development, and delivery of 21st century cures.” 21st Century Cures Act, 130 Stat. at
1033. It includes provisions related to a wide variety of health-related issues, including the
opioid epidemic, drug development, vaccine access, and more. Id. § 1, 130 Stat. at 1033–
35. Notably for our purposes, it seeks to prevent companies from engaging in “information
blocking” of electronic health information. Id. § 4004, 130 Stat. at 1176 (codified as
amended at 42 U.S.C. § 300jj-52).
As relevant here, the Cures Act defines “information blocking” as a practice that,
37
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 38 of 58
“except as required by law or specified by the Secretary [of Health and Human Services]
pursuant to rulemaking . . . , is likely to interfere with, prevent, or materially discourage
access, exchange, or use of electronic health information,” and which “a health information
technology developer, exchange, or network . . . knows, or should know, . . . is likely to”
have these effects. 42 U.S.C. § 300jj-52(a)(1)(A)–(B)(i); see id. § 201(c). As the
Department of Health and Human Services put the point in its related rulemaking, these
statutory provisions “are designed to advance interoperability” and “support the access,
exchange, and use of electronic health information.” 21st Century Cures Act:
Interoperability, Information Blocking, and the ONC Health IT Certification Program, 85
Fed. Reg. 25642, 25643 (May 1, 2020).
PointClickCare concedes that using indecipherable CAPTCHAs and locking users
out facially constitutes information blocking under the Cures Act, absent an applicable
exception. Oral Arg. at 3:40–3:48, https://www.ca4.uscourts.gov/OAarchive/mp3/24-
1773-20250128.mp3. But it contends that its activities do not constitute information
blocking, by definition, because they are activities that “[t]he Secretary, through
rulemaking,” has “identif[ied] [as] reasonable and necessary.” 42 U.S.C. § 300jj-52(a)(3).
It points to three exceptions identified in the regulations: the manner exception, the health-
IT-performance exception, and the security exception.
Before turning to those exceptions, we pause to discuss the question of burden.
PointClickCare took the position below that Real Time had to affirmatively demonstrate
that the exceptions did not apply. See J.A. 965 (PointClickCare arguing that, at the
preliminary-injunction stage, Real Time carries the burden not only of establishing its own
38
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 39 of 58
case, but also “of disproving [PointClickCare’s] case”; that is, Real Time “bear[s] the
burden in eliminating our defenses”). The district court disagreed. See J.A. 885 (court
noting that once Real Time had shown information blocking, “it’s up to the defense to
show that one of these exceptions applies,” which was “the defense[’s] burden”).
On appeal, PointClickCare has repeatedly insisted in a general way that the district
court “misapplied the burden of proof.” Opening Br. at 4. Yet it failed to explain in its
opening brief why the district court was wrong that the exceptions set forth in the
regulations are defenses to the applicability of the information-blocking statute on which
it would bear the burden of proof at trial.
In any event, we think the district court was correct. Assigning the burden in this
way—where Real Time must show that PointClickCare engaged in facial information
blocking, and then the burden shifts to PointClickCare to show that its actions were not
information blocking because a regulatory exception applies—aligns with the purpose of
the Cures Act’s prohibition on information blocking by putting the onus on the party
engaging in such blocking to demonstrate that it is doing so for good reason. And as noted
above, it is well established that “the burdens at the preliminary injunction stage track the
burdens at trial.” Gonzales, 546 U.S. at 429. The district court thus appropriately held
PointClickCare to the burden of establishing that one of the exceptions applied. We do the
same and agree with the district court that PointClickCare has not satisfied that burden
based on the present record.
1.
We begin with the manner exception. That exception provides that “[a]n actor must
39
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 40 of 58
fulfill a request for electronic health information in any manner requested, unless the actor
is technically unable to fulfill the request or cannot reach agreeable terms with the requestor
to fulfill the request in the manner requested.” 45 C.F.R. § 171.301(a)(1) (emphasis added).
“If an actor does not fulfill a request for electronic health information in any manner
requested because it” successfully invokes § 171.301(a)(1), “the actor must fulfill the
request in an alternative manner,” as defined in § 171.301(b)(1). Id. § 171.301(b).
Notably, an actor must fulfill a request for all electronic health information
requested, as defined by 45 C.F.R. § 171.102. Today’s manner exception refers only to the
manner of delivery, not the content to be delivered. And this was a deliberate choice. The
exception was originally labeled the “[c]ontent and manner exception” because it originally
included a content condition. 21st Century Cures Act, 85 Fed. Reg. at 25959 (emphasis
added).
Specifically, when the Department of Health and Human Services enacted the
regulations creating the manner exception in May 2020, it explicitly limited the data that
an actor must provide for the first two years to “the electronic health information identified
by the data elements represented in the USCDI standard adopted in § 170.213.” Id.
(codified as amended at 45 C.F.R. § 171.301). It later extended that deadline for another
five months, until October 2022, due to the COVID pandemic. Information Blocking and
the ONC Health IT Certification Program: Extension of Compliance Dates and Timeframes
in Response to the COVID-19 Public Health Emergency, 85 Fed. Reg. 70064, 70085 (Nov.
4, 2020) (codified as amended at 45 C.F.R. § 171.301). These delays were intended to
ensure that actors would have time to ramp up compliance with the manner exception. 21st
40
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 41 of 58
Century Cures Act, 85 Fed. Reg. at 25795.
However, in 2024, the Department modified the regulation to remove the content
provision and to change the exception’s label to “manner exception” to reflect “that the
‘content’ condition . . . has been moot since October 6, 2022.” Health Data, Technology,
and Interoperability: Certification Program Updates, Algorithm Transparency, and
Information Sharing, 89 Fed. Reg. 1192, 1373 (Jan. 9, 2024); see id. at 1437; cf. id. at 1199
(“On and after October 6, 2022, the scope of [electronic health information] for purposes
of the ‘information blocking’ definition (§ 171.103) is [electronic health information] as
defined in § 171.102.”). The Department was not persuaded against this change by
commenters concerned about situations where they might only be able to fulfill a request
for some of the electronic health information requested. Instead, the Department suggested
that, “[i]n such instances, an actor may want to consider whether another exception is
applicable to any other requested [electronic health information].” Id. at 1373. The
Department’s explanation for the rulemaking thus implies that applicable exceptions to
requests for electronic health information should be analyzed separately for each category
of electronic health information requested. Id.
In the fall of 2023, Real Time made a two-part “request for electronic health
information.” 45 C.F.R. § 171.301(a)(1). PointClickCare has not contended that any of the
sought-after data falls outside the definition of “electronic health information” set forth in
45 C.F.R. § 171.102, so it needed to provide Real Time with both segments of this data
unless an exception applied. The first part, related to roughly 70% of the data Real Time
requires, pertained to the proposed data export. That data-export solution was the focus of
41
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 42 of 58
the district court’s written opinion finding that the manner exception did not apply. Real
Time, 2024 WL 3569493, at *10.
Yet PointClickCare does not grapple with that conclusion at all in its opening
brief. 12 And because PointClickCare has undisputedly blocked Real Time’s access to this
requested data, Real Time is likely to succeed on the merits of its claim on this basis alone
(unless a different exception applies).
For completeness, we nevertheless address the second part of Real Time’s request.
For the other 30% or so of data that Real Time requires, it requested access through the
Marketplace API. PointClickCare does not claim any technical difficulty with granting
such access. Rather, it contends that the parties “cannot reach agreeable terms.” Opening
Br. at 34 (quoting 45 C.F.R. § 171.301(a)(1)).
PointClickCare apparently believes that “cannot reach agreeable terms” has the
same meaning as “have not reached agreeable terms,” even where that lack of agreement
is due to the information-blocking party’s unexplained unwillingness to agree. See J.A.
12
Even if PointClickCare had challenged the district court’s conclusion on this
point, we see no error. As we conclude below, PointClickCare must show some good-faith
efforts to reach agreeable terms before claiming that it “cannot” do so. But PointClickCare
has provided no evidence whatsoever that the data export was technically impossible or
not to its liking for other reasons. To the contrary, it could not provide a reason the
conversations around the matter stopped when repeatedly asked about it by the district
court at the hearing. Nor did it give any reason at oral argument before this Court why the
data-export proposal was not agreeable to it under § 171.301(a), despite being pressed on
the point multiple times. Oral Arg. at 4:35–5:30, 13:20–13:44 (making only an argument
under the alternative-manner section of the regulation, § 171.301(b), even though that
provision is irrelevant if PointClickCare cannot first satisfy § 171.301(a)); see id. at 9:15–
10:39. By contrast, Real Time introduced significant testimony supporting that a data
export would be a relatively simple solution for which it would be willing to pay—both to
build in the first place and for ongoing access.
42
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 43 of 58
939, 945 (PointClickCare arguing before the district court that the fact that the parties had
not reached an agreement, alone, was enough to show the parties “cannot reach agreeable
terms” for purposes of the manner exception); Oral Arg. at 12:31–12:41 (PointClickCare
arguing that the district court erred because of its “legally inaccurate premise that being
unwilling [to come to an agreement] doesn’t get you into the manner exception”).
We disagree. For the phrase “cannot reach agreeable terms” to carry any weight, it
must imply at least some reasonable efforts and articulable reasons why the parties cannot
come to an agreement. See J.A. 951 (district court pointing out that the regulation does not
say “have not reached” agreeable terms, it says “cannot,” implying some level of good
faith and the need to articulate some reason for the impasse (emphasis added)); cf. 21st
Century Cures Act, 85 Fed. Reg. at 25877 (“These provisions will allow actors to first
attempt to negotiate agreements in any manner requested with whatever terms the actor
chooses and at the ‘market’ rate—which supports innovation and competition.”).
That’s because the only reason a defendant would ever invoke the manner
exception—save a technical barrier—would be if the defendant did not want to provide the
information in the manner requested. And why would a defendant go to the trouble of
trying to demonstrate that it was “technically unable to fulfill the request” if it could simply
assert that it had no desire to fulfill the request?
Notably, it is quite difficult to show that a party is “technically unable” to fulfill a
request. “This standard sets a very high bar, and would not be met if the actor is technically
able to fulfill the request, but chooses not to fulfill the request in the manner requested due
to cost, burden, or similar justifications.” 21st Century Cures Act, 85 Fed. Reg. at 25877.
43
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 44 of 58
Rather, cost concerns can be resolved through “charg[ing]” higher “fee[s],” and a truly
burdensome request might be subject instead to the separate “[i]nfeasibility [e]xception.”
Id. (citing 45 C.F.R. § 171.204). If PointClickCare’s interpretation is correct, however, the
actor could skirt the “very high bar” of the “technically unable” prong merely by claiming,
with no need to support its assertion, that it “cannot reach agreeable terms with the
requestor.”
In sum, if PointClickCare’s interpretation is correct—that it can just refuse a request
for electronic health information, and through that refusal bypass § 171.301(a)—that
provision has essentially no meaning.
Consider also the role of 45 C.F.R. § 171.301(b). Under that provision, “[i]f an actor
does not fulfill a request for electronic health information in any manner requested
because” it can satisfy § 171.301(a)(1)—such as by showing that the parties “cannot reach
agreeable terms”—then it “must fulfill the request in an alternative manner,” as set forth in
a preferred order in the regulation. 45 C.F.R. § 171.301(b). PointClickCare contends that
it satisfies the first-preferred alternative manner for the entirety of Real Time’s request by
offering its USCDI system, even though that data only constitutes 30% of Real Time’s
requested data. Id. § 171.301(b)(1)(i); see J.A. 943 (“THE COURT: So if USCDI is only
30 percent of the record that the authorized user needs to perform its role for its customer,
they are just out of luck? [POINTCLICKCARE’S COUNSEL]: At its most basic, that’s
what the regulations require us to do if we fail to reach an agreement, so, yes, Your
Honor.”).
We have already rejected PointClickCare’s interpretation on this point, concluding
44
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 45 of 58
instead that PointClickCare must satisfy the manner exception separately for each category
of requested data. Assuming for the sake of argument that PointClickCare is correct that
its USCDI system would fully qualify as an alternative manner for all of Real Time’s
requested data, however, such an interpretation would further undermine PointClickCare’s
highly limited view of “cannot reach agreeable terms.” As noted, the Department initially
specifically allowed actors to fulfill requests by providing only USCDI-mandated
information for a limited period after the regulation’s enactment. It would be passing
strange if, after those deadlines had come and gone, an actor could invoke its offer of access
to the USCDI system as full compliance with the manner exception merely by claiming
that the parties could not reach agreeable terms.
The district court agreed with this interpretation of the rule. Applying that
interpretation to the facts here, the court found that “the record does not suggest that
[PointClickCare] can find no ‘agreeable terms’ for alternatives. Indeed, the parties were
well on their way to a mutually agreeable alternative whereby Real Time would pay
[PointClickCare] to export the data not otherwise available through [the Marketplace] API.
[PointClickCare] inexplicably chose to end those discussions and so it now cannot reap the
benefit of this exception. In a nutshell, [PointClickCare] appears more unwilling than
unable to reach a mutually agreeable solution. [PointClickCare] cannot take cover under
the manner exception.” Real Time, 2024 WL 3569493, at *10 (citations omitted).
PointClickCare does not argue that the district court committed clear error in its
45
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 46 of 58
factual findings on this point, and we see none. 13 The present record shows that the parties
began negotiations around Marketplace API access, including those related to the
appropriate fee and to the terms of the agreement. Technical employees began building out
the required structure. PointClickCare concedes that it has modified the standard terms of
the agreement before entering contracts with other companies. And it asked Real Time to
send proposed redlines to the agreement. Yet it prematurely cut off talks without
responding to Real Time’s proposed redlines or proposed fee structure. The parties had not
yet reached an impasse; PointClickCare presented its standard terms, Real Time countered,
and PointClickCare simply “went silent,” at which point “the negotiations ceased without
further explanation.” Id. at *3. We agree with the district court that that is not enough to
support PointClickCare’s burden to show that the parties “cannot reach agreeable terms.”
To be sure, is it not our role to flyspeck negotiations between two sophisticated
parties to determine whether they have exhausted every possible avenue of agreement and
force them to return to the negotiating table again and again. But the purpose of the
information-blocking provision of the Cures Act is to encourage the “access, exchange, or
use of electronic health information,” including to ensure that “complete information sets”
13
During the hearing below, the court asked PointClickCare what made it “unable
to continue the conversations,” asking, “is there any testimony that I missed . . . [to the
effect that] what they are asking for is the sun and the moon, and we can’t do it? We can’t
do it technically, it’s too expensive? We told them you have to pay us X dollars, and they
said no? See, I didn’t hear any of that. What I heard was there was a back-and-forth, and
then there wasn’t.” J.A. 939. PointClickCare responded that the parties were simply “not
able to reach an agreement yet. Maybe we will in the future, so it’s a possibility. But to
date, we cannot reach an agreement.” Id. We note that if there remains the “possibility” of
agreement between the parties, it is simply not true that the parties definitively “cannot
reach agreeable terms.” If the door remains open, it remains open.
46
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 47 of 58
are “export[ed]” and that innovative technologies, particularly in “care delivery,” are not
“impede[d].” 42 U.S.C. § 300jj-52(a)(1)(A), (2)(C)(i)–(ii). And the Department of Health
and Human Services has informed us that “each exception is intended to be tailored,
through appropriate conditions, so that it is limited to the reasonable and necessary
activities that it is designed to exempt.” 21st Century Cures Act, 85 Fed. Reg. at 25649.
Further, the Department chose the approach it did in the manner exception “because
[it] believe[s] actors should, first and foremost, attempt to fulfill requests to access,
exchange, or use [electronic health information] in the manner requested” in order to “help
ensure that [electronic health information] is made available where and when it is needed.”
Id. at 25877. It simply cannot be the case that the holder of electronic health information
can get around these statutory and regulatory goals merely by claiming an inability to reach
agreeable terms without any evidence of genuine efforts being made to do so.
2.
PointClickCare also invokes the health-IT-performance and security exceptions. As
relevant here, the health-IT-performance exception provides that “[a]n actor may take
action against a third-party application that is negatively impacting the health IT’s
performance, provided that the practice is . . . [i]mplemented in a consistent and non-
discriminatory manner.” 45 C.F.R. § 171.205(b)(2). Similarly, as relevant here, the
security exception applies where “[a]n actor’s practice that is likely to interfere with the
access, exchange, or use of electronic health information in order to protect the security of
electronic health information” is “tailored to the specific security risk being addressed” and
“implemented in a consistent and non-discriminatory manner.” Id. § 171.203(b)–(c).
47
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 48 of 58
The district court concluded that PointClickCare’s bot-prevention policy was not
“implemented in a consistent and non-discriminatory manner,” precluding
PointClickCare’s reliance on either of these exceptions. Real Time, 2024 WL 3569493, at
*8; see id. at *9–10. Yet again, PointClickCare fails to counter this conclusion in its
opening brief.
In any event, we agree with the district court. It is true that users other than Real
Time’s were watch-listed. However, there is no evidence—beyond the say-so of Fourati,
whose explanations the district court found lacking—as to whether those non-Real-Time
users were in fact presented with indecipherable CAPTCHAs or blocked. Even assuming
they were, Fourati testified that PointClickCare did not know which users belonged to Real
Time (unless the username explicitly referred to Real Time) until Real Time provided a list
of users in May 2024. So, even if other users’ bots were caught up in the same net as Real
Time’s, that does not mean the net was not aimed at Real Time. To the contrary, the timing
of the introduction, escalation, de-escalation, and re-escalation of the CAPTCHAs and
blocking policy—corresponding with PointClickCare’s entrance into the field as a
competitor and various discussions with Real Time, including receiving significant
sensitive information from Real Time under the NDA—is highly suggestive that these
actions were targeted at Real Time. Id. at *10–11.
The sporadic nature of PointClickCare’s challenged actions also demonstrates that
they have not been exercised consistently. First, PointClickCare has not been consistent in
taking action related to bot activity at all. There is no evidence that PointClickCare has
ever sued a customer to enforce the anti-bot provision of its contracts. Real Time used bots
48
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 49 of 58
over many years and never heard a peep from PointClickCare that it objected to their use,
even when Real Time specifically contacted PointClickCare to let it know that it was
reducing its data pulls in light of the initial round of (solvable) CAPTCHAs.
Second, PointClickCare has not implemented the unsolvable CAPTCHAs in a
consistent manner. Real Time introduced testimony that it saw very few unsolvable
CAPTCHAs from roughly February to May 2024. This assertion is supported by
PointClickCare’s own exhibit, which, as the district court noted, showed a user operating
at what was (according to PointClickCare’s criteria) clearly a bot level of resource use from
November 2023 to May 2024 without being watch-listed. PointClickCare’s explanation on
this point was that it was “very reticent . . . to put somebody on a watch list and/or block
them.” J.A. 923. But such “reticence” does not provide a clear metric for consistency. Nor
is it supported by the record, where Real Time introduced uncontradicted testimony that it
was repeatedly swiftly (i.e., within days or weeks) locked out of access to accounts for
hundreds of its skilled-nursing-facility customers that used PointClickCare’s system. Cf.
Opening Br. at 50 (PointClickCare asserting that, “when [it] detects bot activity, it must
act to block the threat to its system”).
We also agree with the district court’s conclusion that PointClickCare’s reliance on
these exceptions fails for other reasons. As relevant here, the health-IT-performance
exception only applies where “a third-party application . . . is negatively impacting the
health IT’s performance.” 45 C.F.R. § 171.205(b). But, other than two charts from April
2023, PointClickCare provided only extremely broad testimony that it experiences
slowdowns caused by bot activity. See Real Time, 2024 WL 3569493, at *5–6. As for those
49
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 50 of 58
two charts, they are from well before any of the challenged actions in this case. And they
show only that a user—one that, according to Fourati, a customer said belonged to Real
Time—was using significant resources around the time that PointClickCare received a
customer complaint regarding system performance. That extremely limited and tenuous
evidence is not enough to demonstrate that Real Time’s bot usage is an ongoing threat to
PointClickCare’s system performance. This is particularly so given that Real Time is a
small player in the grand scheme of PointClickCare’s work: Real Time works with only
1,400 of PointClickCare’s 27,000 facilities (or five percent), and PointClickCare itself
pushes out 1.2 million medication administrations per day by automated process. See J.A.
957 (district court raising doubts about Fourati’s testimony as “vague and nonspecific and
unsupported” because he also testified to PointClickCare “push[ing] out 1.2 million
medication administrations a day . . . by automated activity” with no issue); Real Time,
2024 WL 3569493, at *6, *8.
PointClickCare also did not introduce any evidence to indicate that it had ongoing
service issues for the decade during which Real Time was using bots to access its system;
that its performance improved when Real Time reduced its number of data pulls by half
(and then by half again); or that its system’s performance improved when it introduced
indecipherable CAPTCHAs and locked Real Time’s users out. Further underlining the
tenuousness of PointClickCare’s alleged performance concerns is one of its own
declarations: an executive at a senior-care provider stated that his company relied on
PointClickCare’s systems and explained that while his company had “generally never had
a problem accessing any of PointClickCare’s services,” there had been “a handful of
50
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 51 of 58
instances” where employees complained about the systems “working at a slower rate than
usual,” which PointClickCare “informed [them] . . . may be caused when vendors engage
in an excessive use of the system which may cause system timeouts.” J.A. 330 (emphasis
added).
Simply put, while PointClickCare could eventually come forward with evidence that
Real Time’s bot usage “negatively impact[s] [its] performance,” 45 C.F.R. § 171.205(b),
it has to date failed to carry its burden to establish that basic fact.
As for the security exception, an act that would otherwise constitute information
blocking only falls under that exception if it is “tailored to the specific security risk being
addressed.” Id. § 171.203(b). But PointClickCare has failed to articulate a specific security
risk posed by Real Time’s bot access, instead gesturing very broadly to the potential
malicious use of bots. Real Time, 2024 WL 3569493, at *9–10.
In fact, instead of providing evidence, PointClickCare baldly argues that the notion
“that third-party bots are a systemic security risk to its platform” is “an obvious point that
should not require documentation.” Opening Br. at 4. But any access to any electronic
system poses security risks, so that kind of vague assertion is not enough to evade the
statutory ban on information blocking. And there is no evidence that Real Time’s use of
bots in PointClickCare’s system has ever led to any security breach; in fact, there is no
evidence of a security breach experienced by Real Time at all. Moreover, Real Time
possesses the highest level of security certification. There is simply no evidence that Real
Time’s use of bots poses a genuine security concern for PointClickCare. See Real Time,
2024 WL 3569493, at *3 n.2 (“Real Time . . . seems to pose no identifiable security threat
51
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 52 of 58
to [PointClickCare].”).
Further, even if PointClickCare is truly concerned about users downloading vast
quantities of data from its systems, it did not express this concern for years before it started
seeking to become a competitor. Human users, to which it does not object, can also
download such vast quantities of data. See id. (finding that Real Time’s “automated
software poses no greater risk of a security breach than that associated with human users”).
And more tailored means are available—simply obtaining usernames from Real Time (or
from its customer) would allow PointClickCare to ensure that a user it sees downloading
large quantities of data is an authorized one, and performing random quality checks such
as contacting Real Time or its customer when it sees a user downloading large quantities
of data would enable it to ensure the authorized user’s IP address was not being “spoofed”
by a nefarious actor. See J.A. 489 (noting that spoofing is when a malicious actor makes
“their IP address . . . look like somebody else’s IP address”).
In sum, we agree with the district court that none of the exceptions that
PointClickCare invokes apply. Real Time is likely to succeed on the merits of its claim that
PointClickCare’s use of indecipherable CAPTCHAs and blocking of user accounts
constitutes information blocking under the Cures Act.
D.
Finally, PointClickCare argues that even if we conclude that Real Time can rely on
the Cures Act in part to establish an unfair-competition claim, and even if its actions violate
the Cures Act, Real Time is nevertheless unlikely to succeed on the merits of its unfair-
competition claim because (1) it cannot satisfy the other elements of that claim and (2) such
52
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 53 of 58
an interpretation of the Cures Act would pose an avoidable constitutional concern. We
disagree.
PointClickCare argues that even if its actions violate the Cures Act, Real Time
“cannot show that PointClickCare engaged in any sort of fraud or deception,” which “is
fatal to its unfair-competition claim.” Opening Br. at 65. That is wrong. As noted, the law
of unfair competition includes “damaging or jeopardizing another’s business by fraud,
deceit, trickery or unfair methods of any sort.” Balt. Bedding Corp., 34 A.2d at 342
(emphasis added); accord Mascaro v. Snelling & Snelling of Balt., Inc., 243 A.2d 1, 10
(Md. 1968) (“As the law developed, proof of fraudulent deception was no longer essential
for relief, and this is the Maryland rule.”); Paccar, 905 F. Supp. 2d at 690–92 (reviewing
relevant case law). Illegal actions directed at a competitor are unfair. Cf. Command Tech.,
2015 WL 6470277, at *8. And at bottom, we agree with the district court that the present
record strongly supports an inference that PointClickCare sought to leverage its control
over its EHR system to harm Real Time’s business, and that its cited reasons for its actions
(security and system performance) were a cover for its true motivations (hurting a
competitor). See Real Time, 2024 WL 3569493, at *11.
PointClickCare also argues that “[t]he district court’s misinterpretation of the Cures
Act raises grave constitutional questions” under the Takings Clause and urges this Court
to employ the constitutional-avoidance canon to interpret the Act differently. Opening Br.
at 53. Yet it does not even cite, much less explain how the facts of this case would satisfy,
the factors relevant to a takings claim of this type. See Blackburn v. Dare County, 58 F.4th
807, 810–11 & n.3 (4th Cir. 2023). Thus, we decline to address this argument.
53
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 54 of 58
We affirm the district court’s conclusion that Real Time is likely to succeed on the
merits of its unfair-competition claim. We therefore do not reach the tortious-interference
claim.
IV.
Because we agree with the district court that Real Time has demonstrated a
sufficient likelihood of success on the merits of at least one of its claims, we turn to the
remaining preliminary-injunction factors. We agree with the district court that Real Time
has satisfied them.
A.
First is the question of irreparable harm. The district court correctly noted that
irreparable harm can include “actual and imminent” “loss of good will or erosion of [a
company’s] customer base.” Real Time, 2024 WL 3569493, at *12; see Multi-Channel TV
Cable Co. v. Charlottesville Quality Cable Operating Co., 22 F.3d 546, 552 (4th Cir. 1994)
(describing the “permanent loss of customers to a competitor or the loss of goodwill” as a
form of irreparable injury), abrogated in part on other grounds by Winter, 555 U.S. 7; Air
Evac EMS, Inc. v. McVey, 37 F.4th 89, 103 (4th Cir. 2022) (noting impending likely “loss
of customers and employees” as irreparable harm).
PointClickCare’s actions threaten exactly that: every time Real Time must reach out
to a customer to ask them to reset an account, it wastes the customer’s time and looks
incompetent to the customer. And every time Real Time’s access to the records for a given
nursing home is disrupted, that is “a 100% business interruption” with that facility. Real
Time, 2024 WL 3569493, at *12. The disruption of Real Time’s ability to do its work with
54
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 55 of 58
hundreds of facilities at a time—700 and 600 in November 2023 and May 2024,
respectively, out of its 1,700 customer facilities—puts it at immediate risk of breach of its
contracts with its customers and “presents a real and imminent threat to [its] continued
ability to do business.” Id.; see J.A. 428 (Dr. Rifkin conceding that Real Time has not yet
received notice from a customer that the customer was terminating a contract related to the
loss of service, but attributing this to the fact that Real Time “ha[s] been able to provide
service because [PointClickCare] backed off on the CAPTCHAs” in light of the litigation);
J.A. 438 (Dr. Rifkin testifying that Real Time “will be out of business within weeks if [it
is] shut off from the data”); J.A. 611–12 (Buono agreeing with Dr. Rifkin’s assessment and
explaining that most of Real Time’s revenue comes from larger contracts, like that with
CRISP, and that “given PointClickCare’s market share,” if PointClickCare cuts off Real
Time’s access, Real Time would not be able to “perform the analytics” it is required to
perform under those contracts).
While PointClickCare argues that Real Time could access the data in other ways,
the record does not support any immediately viable alternatives that would avoid these
irreparable harms. The Marketplace or USCDI systems provide only about 30% of the
necessary data and involve a contract that, without modifications, would arguably place
Real Time in immediate breach. Hiring 450 humans to replace the bots would risk breach
of Real Time’s contracts with its customers during the significant time it would take to hire
and train these individuals, and would carry a substantial risk of financial ruin once they
were hired because the cost of staffing would exceed Real Time’s revenues from its
customers. The only truly viable alternatives—a modified data relay or data export
55
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 56 of 58
combined with the Marketplace—are ones that PointClickCare has refused to allow Real
Time to pursue.
B.
Next is the matter of the balance of the equities. The district court concluded that
“were [PointClickCare] permitted to use unsolvable CAPTCHAs in the future, Real Time
would face unpredictable, unplanned widespread business outages akin to that which it has
withstood before. [PointClickCare], on the other hand, has given the Court no reason to
believe that eliminating the use of such unsolvable CAPTCHAs would visit any harm to
it. The narrow relief requested leaves intact nearly all of [PointClickCare]’s existing
security protocol, including the use of solvable CAPTCHAs, and enjoins solely the use of
unsolvable CAPTCHAs which do not rationally relate to the provision of security in any
event.” Real Time, 2024 WL 3569493, at *12.
We agree. Solvable CAPTCHAs will still stop some bots from accessing
PointClickCare’s systems, and as discussed, it has presented no more than broad-strokes
evidence that bots pose a risk to its systems anyway. On the flip side, allowing it to use
unsolvable CAPTCHAs will rapidly place Real Time in an untenable position, as described
above. Further, as the district court noted, even if Real Time pursued the supposed
“solution” of hiring 450 human users, it is not clear this would be better for either party.
Rather, it “stands to reason that automated software used by a company with the highest
security certification remains more secure than if the same company had to employ 450
individuals to perform the same task.” Id. at *9 n.5. It also seems highly likely that utilizing
450 human staff members to download the needed data would introduce more errors into
56
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 57 of 58
that data, risking Real Time’s ability to perform its role quickly and accurately. Balancing
the potential harms to Real Time from not having an injunction against those to
PointClickCare from having one, we readily agree with the district court that the equities
favor Real Time’s position.
C.
Finally, we must consider the public interest. The district court focused on the
benefits provided by Real Time’s services. Id. at *12. PointClickCare made clear below
that it does not dispute that Real Time provides meaningful services, the continuation of
which is in the public interest. And the record supports that Real Time’s inability to perform
its work threatens real harm to patients, including the very real potential for increased
nursing-home deaths. One witness who works closely with Maryland’s CRISP program
testified that, if Real Time stopped being able to provide its services to CRISP, “for want
of another substitute that would immediately step in and do that, people are at risk of
death”—and that such an immediate substitute was unlikely because the state government’s
request-for-proposal process moves slowly, so CRISP would not be able to “pivot quickly
to find another . . . service supplier.” J.A. 567, 570. He also explained that the patients at
risk are “not only the oldest and most vulnerable Marylanders, they are also, by definition,
the poorest” and “don’t have the options to be in a high-level assisted living community or
to have . . . around-the-clock home care.” J.A. 571.
Of course, PointClickCare also provides valuable services, so a genuine threat to
those services would be of grave concern as well. But we agree with the district court that
the evidence suggests that Real Time’s use of bots does not pose a risk to PointClickCare’s
57
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 58 of 58
ability to do its business—and certainly not such a grave risk so as to outweigh the threat
that PointClickCare’s use of indecipherable CAPTCHAs and user blocking poses to Real
Time’s ability to provide its valuable services. In fact, as the district court found, it appears
likely that such a threat to Real Time’s ability to provide its services was precisely the point
of PointClickCare’s enjoined actions. Real Time, 2024 WL 3569493, at *11. The public
interest does not weigh in favor of such anticompetitive and harmful behavior.
V.
For the foregoing reasons, we affirm the district court’s order granting a preliminary
injunction to Real Time.
AFFIRMED
58
Plain English Summary
USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 1 of 58 PUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No.
Key Points
01USCA4 Appeal: 24-1773 Doc: 52 Filed: 03/12/2025 Pg: 1 of 58 PUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No.
0224-1773 REAL TIME MEDICAL SYSTEMS, INC., Plaintiff - Appellee, v.